Answers are grounded in this paper and cite their sources.
Analogs of immunodominant myelin peptides involved in multiple sclerosis (MS: the most common autoimmune disease) have been extensively used to modify the immune response over the progression of the disease. The immunodominant 35–55 epitope of myelin oligodendrocyte glycoprotein (MOG 35–55 ) is an autoantigen appearing in MS and stimulates the encephalitogenic T cells, whereas mannan polysaccharide ( Saccharomyces cerevisiae ) is a carrier toward the mannose receptor of dendritic cells and macrophages. The conjugate of mannan‐MOG 35–55 has been extensively studied for the inhibition of chronic experimental autoimmune encephalomyelitis (EAE: an animal model of MS) by inducing antigen‐specific immune tolerance against the clinical symptoms of EAE in mice. Moreover, it presents a promising approach for the immunotherapy of MS under clinical investigation. In this study, a competitive enzyme‐linked immunosorbent assay (ELISA) was developed to detect the MOG 35–55 peptide that is conjugated to mannan. Intra‐ and inter ‐day assay experiments proved that the proposed ELISA methodology is accurate and reliable and could be used in the following applications: (i) to identify the peptide (antigen) while it is conjugated to mannan and (ii) to adequately address the alterations that the MOG 35–55 peptide may undergo when it is bound to mannan during production and stability studies.
No takes yet. Share an insight, caveat, or question.
Gkika et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: